David Park, MD, PhD, is a neurosurgeon who graduated medical school from the Catholic University of Korea in Seoul, South Korea. He then completed his internship and residency training in the Department of Neurosurgery, Seoul St. Mary’s Hospital. He became a board-certified neurosurgeon in South Korea in 2014 and then completed his 2-year fellowship in the same hospital in the fields of brain tumor surgery and skull base surgery. During his residency training, he attended graduate school while practicing neurosurgery as a trainee. He successfully defended his Ph.D. thesis titled “Combination therapy for gliomas using temozolomide and interferon-beta secreting human bone marrow-derived mesenchymal stem cells.” in 2015. After completing his fellowship in South Korea, Dr. Park moved to Singapore in 2016. He worked as a clinical fellow (clinical associate) for one year at the National Neuroscience Institute, focusing on Neurosurgical Oncology and Skull base surgery. In 2017, Dr. Park joined Dr. Christian Badr’s lab at the Massachusetts General Hospital, Harvard Medical School, as a postdoctoral research fellow to perform translational research on glioblastoma to complement his clinical expertise. His research focused on the role of fatty acids and lipid metabolism in glioblastoma. During this period, in addition to his work in the lab, Dr. Park launched his own start-up business based on his invention. He came up with the idea of an intraoperative diagnostic tool for tumor detection during glioma surgery, collaborated with bioengineers at M.I.T. to develop a prototype, and received seed funding from the MIT Sandbox Innovation Fund. As an MIT Sandbox program alumnus, he continues to work on this project. In 2020, Dr. Park joined the North Shore University Hospital, Zucker School of Medicine at Hofstra/Northwell in Long Island, New York, as a Neurosurgical Oncology and Radiosurgery Fellow (Teaching Associate). During this one-year fellowship, he worked with Dr. Michael Schulder focusing on brain tumor surgery including laser interstitial thermal therapy (LITT) and stereotactic radiosurgery (SRS). From July 2021 to June 2022, Dr. Park completed a Neurosurgical Oncology and Radiosurgery Fellowship at the Cleveland Clinic in Cleveland. He devoted his efforts to minimally invasive neurosurgical techniques such as LITT and Gamma Knife SRS, as well as awake brain tumor surgery under the guidance of Drs. Gene Barnett, Lilyana Angelov, and Ali Mohammadi. In July 2022, Dr. Park joined the Department of Neurosurgery at Stanford University as a Clinical Instructor. Dr. Park now works with Drs. Steven D. Chang and Antonio Meola in the field of Cyberknife stereotactic radiosurgery and Neurosurgical oncology.